COVID-19 and SLE patients share many common hub genes, related pathways and regulatory networks. Based on these common targets, we found many potential drugs that could be used in treating patient with COVID-19 or COVID-19 combined with SLE.
Keyphrases
- coronavirus disease
- systemic lupus erythematosus
- sars cov
- disease activity
- respiratory syndrome coronavirus
- ejection fraction
- newly diagnosed
- prognostic factors
- rheumatoid arthritis
- transcription factor
- genome wide
- dna methylation
- gene expression
- risk assessment
- human health
- bioinformatics analysis
- genome wide identification